Kidney Tubular Biomarkers in Type 1 Diabetes - Longitudinal Analysis of 2 Cohorts
Authors:
- Christine P. LimonteCLChristine P. Limonte
- David K. PrinceDPDavid K. Prince
- Andrew N. HoofnagleAHAndrew N. Hoofnagle
- Irl B. HirschIHIrl B. Hirsch
- Sushrut S. WaikarSWSushrut S. Waikar
- Alessandro DoriaADAlessandro Doria
- Michael MauerMMMichael Mauer
- Bryan R. KestenbaumBKBryan R. Kestenbaum
- Ian H. de BoerIBIan H. de Boer
Open Access
- 6 May 2025
- journal article
- Published by Elsevier in Kidney International Reports
- Vol. 10 (7) , 2311-2322
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (P30 DK035816)
- National Institutes of Health (5R01DK129318)
- National Institutes of Health (K23DK135789)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK132399)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125084)
This publication has 41 references indexed in Scilit:
- Longitudinal Trajectories of Biomarkers of Kidney Tubular Function in Type 1 DiabetesKidney International Reports, 2024
- Population-Based Limits of Urine Creatinine ExcretionKidney International Reports, 2022
- Molecular mechanisms and therapeutic targets for diabetic kidney diseaseKidney International, 2022
- Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes RegistryDiabetes Research and Clinical Practice, 2022
- A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disordersKidney International, 2021
- Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort studyJournal of Diabetes and its Complications, 2019
- Kidney Tubular Damage and Functional Biomarkers in Acute Kidney Injury Following Cardiac SurgeryKidney International Reports, 2019
- Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseDiabetologia, 2019
- A more tubulocentric view of diabetic kidney diseaseJournal Of Nephrology, 2017
- Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjectsActa Diabetologica, 2011